Surviving with HIV in the HAART era: emerging challenges.
It is clear that metabolic disorders and cancers will continue to be important risks for HIV-infected individuals, especially in the long term. Patients must be aware of new potential risks and, when possible, take preventive measures. In this context, HIV becomes one major aspect of a patient's health, but not the entire focus. By concentrating on the changing aspects of HIV disease, researchers and physicians are keeping pace with a disease that always reveals new information not only about itself, but also on how the immune system functions.
Gegeny
T
T
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000503:physiopathology